TGFB facilitates the conversion of naive CD4+ T cells into CD4+Foxp3+ regulatory T-cells (Tregs), which inhibit anti-tumor immunity, thereby promoting tumor progression [31]. This evidence concerns the gene TGFB1 and neoplasm.